IJCRR - 6(11), June, 2014
ROLE OF OXIDATIVE STRESS IN DIABETIC RETINOPATHY
Author: Sri Hari Atti, Angirekula Saseekala, Varun Siri A.
Objective: Diabetic retinopathy is the most commonest form of complications of diabetes mellitus which leads to vision loss if untreated. It has been hypothesized that oxidative damage may be involved in the pathogenesis of development of diabetic retinopathy. The aim of our present study is to evaluate the role of oxidative stress in diabetic retinopathy patients. Methods: We tried to assess the role of oxidative stress in patients by estimating the levels of lipid peroxidation assessing plasma Malondialdehyde(MDA) levels and antioxidant status by reduced glutathione(GSH), Vitamin-E ,Vitamin-C in blood. For this, we have taken 50 cases of diabetic retinopathy compared with 25 age matched controls . Results: There were significant increase in the levels of MDA and significant decreases in the levels of antioxidants like GSH, vitamin-E and Vitamin-C in patients when compared with controls. Conclusion: Our results indicate that oxidative stress is associated with the development of diabetic retinopathy which needs further studies.
Keywords: Diabetes, retinopathy, oxidative stress, antioxidants.
Sri Hari Atti, Angirekula Saseekala, Varun Siri A.. ROLE OF OXIDATIVE STRESS IN DIABETIC RETINOPATHY International Journal of Current Research and Review. 6(11), June, 91-96
1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care, 2004;27:1047-1053.
2. Gupta.M.M, Chari.S. Lipid peroxidation and the antioxidant status in patients with diabetic retinopathy. Indian J Physiol Pharmacol, 2005;49(2):187-192.
3. Nguyen TT, Alibrahim E, Islam FM et al. Inflammatory, hemostatic and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. Diabetes Care 2009;32:1704-9.
4. Kowluru RA, Atasi L, Ho YS. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest Ophthal Vis Sci, 2006; 47(4):1594- 1599.
5. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001;414(6865):813-820.
6. Soliman GZA. Blood lipid peroxidation(superoxide dismutase,Malondialdehyde,glutathione) levels in Egyptian type 2 diabetic patients. Singapore Med J, 2008;49(2):129- 136.
7. Van den Enden MK, Nyengaard JR, Ostro WE, Burgan JH, Williamson JR. Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism: implications for diabetic retinopathy. Invest Ophthalmol Vis Sci, 1995;36:1675- 1685.
8. Williamson JR, Chang K, Frangos M et al. Hyperglycemic pseudohypoxia and diabetic complications( Perspectives in Diabetes). Diabetes, 1993;42:801-813.
9. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol, 1995;113:1538-1544.
10. Lu M, Kuroki M et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest,1998;101:1219-1224.
11. Armstrong D, Ueda T et al. Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet derived growth factor. Angiogenesis,1998;2:93-104.
12. Yagi K. Lipid peroxides and human diseases. Chem Phys Lipids,1978;45:337- 351.
13. Sinnhuber RO, Yu TC. Characterization of red pigment formed in thiobarbituric acid determination of oxidative rancidity. Food Res,1958;23:626-630.
14. Beutler E, Duron O, Kelly BM. Improved method for determination of blood glutathione. J Lab Clin Med, 1963;61:882- 888.
15. Baker and Frank. Determination of serum tocopherol by colorimetric method. In Varley’s practical clinical biochemistry, Heinmann professional publishing 1998;6th edition.902.
16. Tietz NW(Ed). Textbook of Clinical Chemistry. W.B.Saunders Company, Philadelphia, London, Toronto.2004;pp.960- 962.
17. Kempen JH, O’ colmain BJ et al. Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol, 2004;122:552-563.
18. International Diabetes Federation. The Diabetes Atlas, 2009; 4th edition. Brussels. 19. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. New Engl J Med,1993;329:977-986.
20. Rema M, Prem kumar S et al. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study(CURES) eye study. Invest Ophthalmol Vis Sci,2005;46:2328-33.
21. Rema M, Ponnaiya M, Mohan M. Prevalence of retinopathy in non insulin dependent diabetes mellitus at a diabetes center in southern India. Diab Res Clin Pract.1996;34:29-36.
22. Nirmalan PK, Katz J, Robin AL et al. Prevalence of vitreoretinal disorders in a rural population of Southern India: the Aravind Comprehensive Eye Study. Arch Ophthalmol,2004;122:581-586.
23. Kim TW.Pathogenesis of diabetic retinopathy. J Korean Diabetes Assoc,1997;21:115-21.
24. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature,2001;414:813-20.
25. Sundaram RK, Bhaskar A, Vijayalingam S et al. Antioxidant status and lipid peroxidation in type 2 diabetes mellitus with and without complications. Clin Sci,1996;90:255-60.
26. Jain SK, Mc Vie R, Jaramillo JI et al. The effect of modest vitamin E supplementation or lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids,1996;31:87-90.